CClinicalTrials.gg
CompletedNCT05656859Updated Sep 19, 2024

Prevalence of Eating Disorder Symptomatology Among Outpatients Referred to Health Promotion from Somatic Hospital Departments

An observational study in Eating Disorders, sponsored by Aalborg University Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Aalborg University Hospital · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
136
Ages
18 Years and older
Sex
All
01

Study summary

The Department of Health Promotion at Aalborg University Hospital gets patients referred from all the hospital's departments. The Department of Health Promotion offers lifestyle courses to aid preventing disease relapses and further comorbidities to patients referred to other ambulatory treatments at the hospital. For most patients this also includes weight loss, but the primary goal is lifestyle change regarding eating and exercise habits to improve overall health state. Since it is known that eating disorders commonly occurs in individuals seeking help for weight loss, and that the prevalence is larger than in the background population, we also suspect that eating disorders would commonly occur among patients referred to the Department of Health Promotion. Therefore, we aim to investigate the prevalence of eating disorders among patients referred to lifestyle courses at the Department of Health Promotion.

02

Conditions studied

  • Eating Disorders
03

In context

Feeding and Eating Disorders

740 studies on the registry are indexed under Feeding and Eating Disorders; 159 are open to participants now.

This study's enrollment of 136 is above the median of 100 across 183 observational studies indexed under Feeding and Eating Disorders.

Browse Feeding and Eating Disorders studies →

Lead sponsor

Aalborg University Hospital is the lead sponsor of 195 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients referred to the Department of Health Promotion

Inclusion criteria

  • Patients referred to the Department of Health Promotion at Aalborg University Hospital, Denmark

Exclusion criteria

Exclusion Criteria:

  • Under age 18
  • Not able to read and understand Danish
  • Not able to recieve mail in the danish digital postbox, e-Boks
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
136 participants (actual)
Patient registry
No

Groups and cohorts

  • Study group

    Descriptive study

    Behavioral: Single group

Interventions

  • BehavioralSingle group

    Survey

06

What researchers measure

Primary outcomes

  1. Eating Disorder Examination Questionnaire (EDE-Q)

    The Eating Disorder Examination Questionnaire (EDE-Q) is a 28-item self-reported questionnaire adapted from the semi-structured interview Eating Disorder Examination (EDE) and designed to assess the range and severity of features associated with a diagnosis of eating disorder using 4 subscales (Restraint, Eating Concern, Shape Concern and Weight Concern) and a global score. The EDE-Q generates two types of data: frequency data on key behavioural features of eating disorders in terms of number of episodes of the behaviour, and subscale scores reflecting the severity of characteristics of eating disorders. Higher scores on the global scale and subscales denote more problematic eating behaviours and attitudes.

    Time frame: 10 minutes

Secondary outcomes

  1. Binge Eating Disorder Questionnaire (BED-Q)

    The Binge Eating Disorder Questionnaire (BED-Q) is a 9-item self-reported questionnaire. Items are rated on a 5-point Likert-type rating scale. Scores range between 0-32 and higher scores denote more problematic binge eating disorder. A diagnostic score that determine patient is diagnosed with Binge Eating Disorder or not can be calculated. 1 item rated "yes" or "no and other items are used to calculated a diagnostic score.

    Time frame: 5 minutes

  2. Grazing Questionnaire (GQ)

    Grazing Questionnaire (GQ) is a 8-item self-reported questionnaire to measure behaviours and cognitions specific to grazing. Items are rated on a 5-point Likert-type rating scale where higher scores represent more grazing behaviours and cognitions. Scores are summes to form a total score (range: 0-32).

    Time frame: 5 minutes

Other outcomes

  1. The 5-level EQ-5D version (EQ-5D-5L)

    Self-reported quality of life questionnaire. The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflect the patient's own judgement.

    Time frame: 5 minutes

07

Study locations

1 site
  • Aalborg University Hospital
    Aalborg, North of Jutland 9000, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05656859
Lead sponsor
Aalborg University Hospital
Responsible party
Tobias Christensen (Principal Investigator, Aalborg University Hospital) — Principal investigator
First posted
Dec 19, 2022
Start date
Sep 6, 2022
Primary completion
Mar 31, 2023
Completion
Dec 31, 2023
Last update
Sep 19, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion